Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Mustea

Showing results (151-160 of 172) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|June 30, 2018
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
In Vivo (Athens, Greece)|October 30, 2025
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in GermanyJohanna Ernst, Katharina Alfter, Alexander Mustea, et al.
American Journal of Obstetrics and Gynecology|January 16, 2021
p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study groupLinn Woelber, Katharina Prieske, Christine Eulenburg, et al.
The New England Journal of Medicine|February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsPhilipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Annals of Surgical Oncology|November 30, 2016
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 StudyRüdiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Clinical and Translational Radiation Oncology|November 29, 2023
Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trialCas Stefaan Dejonckheere, Julian Philipp Layer, Younèss Nour, et al.
Geburtshilfe Und Frauenheilkunde|April 8, 2025
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)Markus Wallwiener, Marco Johannes Battista, Eike-Christian Burandt, et al.
Geburtshilfe Und Frauenheilkunde|December 9, 2020
Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?Linn Woelber, Mareike Bommert, Katharina Prieske, et al.
Pageof 18

Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|June 30, 2018
Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
In Vivo (Athens, Greece)|October 30, 2025
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in GermanyJohanna Ernst, Katharina Alfter, Alexander Mustea, et al.
American Journal of Obstetrics and Gynecology|January 16, 2021
p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study groupLinn Woelber, Katharina Prieske, Christine Eulenburg, et al.
The New England Journal of Medicine|February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsPhilipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Geburtshilfe Und Frauenheilkunde|October 29, 2019
Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Annals of Surgical Oncology|November 30, 2016
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 StudyRüdiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Geburtshilfe Und Frauenheilkunde|December 5, 2022
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021)Dominik Denschlag, Sven Ackermann, Marco Johannes Battista, et al.
Clinical and Translational Radiation Oncology|November 29, 2023
Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trialCas Stefaan Dejonckheere, Julian Philipp Layer, Younèss Nour, et al.
Geburtshilfe Und Frauenheilkunde|April 8, 2025
Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, June 2024)Markus Wallwiener, Marco Johannes Battista, Eike-Christian Burandt, et al.
Geburtshilfe Und Frauenheilkunde|December 9, 2020
Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?Linn Woelber, Mareike Bommert, Katharina Prieske, et al.
Pageof 18